-
Featured Press Release
Aspira Women’s Health Reports First Quarter 2022 Financial Results
Learn More -
Press Release
Aspira Women’s Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11
Learn More -
Press Release
Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results
Learn More
Recent News
Choose a Category:
-
Valerie Palmieri Elevated to Executive Chair of the Board; Nicole Sandford Appointed President and CEO
Press Release
Expanded leadership team to drive strategic partnerships, accelerate new commercial launches, and grow overall enterprise value AUSTIN, Texas —February 25, 2022 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today named Valerie Palmieri as Executive Chair of the Board, and Nicole Sandford as President and CEO of the Company. Jim LaFrance,…
-
Aspira Women’s Health Announces the Addition of 465,000 Covered Lives Through Medicaid Credentialing
Press Release
AUSTIN, Texas — January 31, 2022 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, announced today that it has entered into agreements to provide its testing services to Medicaid plan members in the state of New Hampshire and Washington, D.C equaling nearly a half million covered lives. The state of New Hampshire covers…
-
Aspira Women’s Health Appoints Minh Merchant as General Counsel
Press Release
AUSTIN, Texas —Jan. 5, 2022 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that Minh Merchant will join the Company as General Counsel and Corporate Secretary, effective Jan. 4, 2022. In this role, Ms. Merchant will lead the Company’s legal, compliance, and enterprise risk management functions, reporting to Valerie…
-
Aspira Women’s Health Executes an Agreement with Axia Women’s Health to Launch Aspira Synergy Genetics Platform
Press Release
Axia Women’s Health is one of the largest women’s health networks in the United States serving nearly half a million women a year AUSTIN, Texas —January 5, 2022 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, announced today that it has entered into a commercial enterprise agreement with Axia Women’s Health,…
-
Aspira Women’s Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs
Press Release
Fourth quarter OVA1 volume grew 23.4% to 4,750 units Plans underway for staged launches of EndoCheck and OvaWatch AUSTIN, Texas —Jan 5, 2022 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced preliminary fourth quarter operational results and provided a corporate update. Operational Metrics Update OVA1® volume in the fourth…